M. Nishimura et al.: Arterial Thrombosis in Nephrotic Syndrome
665
Table 2. Reported cases of lower extremity arterial thrombosis in adult cases of neph-
rotic syndrome
Case;
First author
Age
Prior
Serum
Renal
Ref.
(years)/sex treatment albumin (g/dl) histology
Outcome
1
2
3
4
5
6
7
. Mukherjee4
24/M
34/M
40/M
25/M
23/M
29/M
39/M
S
D
0.65
—
1.5
0.92
0.7
1.5
1.5
PGN
RAKA
BBKA
RAKA
Recovered
Died
Recovered
Recovered
5
. Patel
FPGN
PGN
PGN
MCGN
MCGN
MCGN
. Nitatori6
S/D
S/D
None
S
6
. Nitatori
7
. Parag
. Khatri8
. Present case
None
PGN, proliferative glomerulonephritis; FPGN, focal proliferative GN; MCGN, minimal change
GN; RAKA, right above-knee amputation; BBKA, bilateral below-knee amputation; S, steroids;
D, diuretics
blood. The mechanism of hypercoagulability, however,
has not yet been clearly elucidated. A reduction in low
molecular weight coagulation factors (XI, XII) results
from an increased loss in the urine, so that levels of high
molecular weight factors (V, VII, VIII, IX, X, XIII)
become elevated as a result of increased protein syn-
thesis. Notably, an elevation in the fibrinogen level is a
significant abnormality in nephrotic syndrome and has
been shown to considerably alter the plasma viscosity.
Antithrombin III, an important anticoagulant factor,
has a molecular weight similar to that of albumin and is
lost in much the same manner. There is also a significant
positive correlation between the serum levels of anti-
thrombin III and albumin. Low levels of antithrombin
III have been shown to occur in as many as 80% of
patients with nephrosis.1 Various other conditions
associated with nephrotic syndrome, including plasma
lipid abnormalities, hypovolemia with hypoalbumin-
emia, hypertension, circulating immune complexes, and
susceptibility to infection, are also considered to be fac-
tors contributing to the hypercoagulable state in neph-
rotic syndrome. Recently, a deficiency in free protein S
has also been implicated as a contributing factor in
Anticoagulation therapy is essential to prevent throm-
bosis, to improve the outcome, and to prevent progres-
sive glomerular mesangial fibrosis. Though Nitatori
6
et al. recommend long-term heparin therapy, heparin
may be ineffective for the treatment of antithrombin III
deficiency in nephrotic syndrome, because the mecha-
nism of heparin is the enhancement of the antithrombin
III activity. However, the extent of antithrombin III
deficiency in nephrosis is usually such that substantial
heparin resistance is not encountered.
Therefore, if extremely low levels of antithrombin III
are documented, operative treatment should be accom-
panied by the administration of antithrombin III so that
adequate anticoagulation can be achieved with heparin.
It is also necessary to closely monitor the occurrence
and recurrence of thrombosis when steroids are admin-
istered because steroids tend to worsen the preexisting
tendency of the blood to coagulate.
References
2
thrombotic diathesis. The use of diuretics increases the
1. Vaziri ND, Paule P, Toohey J, Hunge E, Alikhani S, Darwish R,
Paul MV (1984) Acquired deficiency and urinary excretion anti-
thrombin III in nephrotic syndrome. Arch Intern Med 144:1802–
viscosity of the blood. Steroids alter the coagulation
state by increasing factor VIII and other serum pro-
teins, and by decreasing the fibrinolytic activity.
1
803
2
. Siddiqi FA, Tepler J, Fantini GA (1997) Acquired protein S
and antithrombin III deficiency caused by nephrotic syndrome:
an unusual cause of graft thrombosis. J Vasc Surg 25:576–580
. Cameron JS, Ogg CS, Ellis FG, Salmon MA (1971) Femoral
arterial thrombosis in nephrotic syndrome. Arch Dis Child 46:
215–216
3
Cameron et al. recommended that steroid therapy
should be replaced by cyclophosphamide therapy.
3
4
–8
Table 2 summarizes the reported cases of lower
extremity arterial thrombosis in adult patients with
nephrotic syndrome. The findings clearly reflect the
poor outcome. Three cases culminated in an amputa-
tion of the leg and two of these three also sustained
4. Mukherjee AO, Toh BH, Chan GL, Lau KS, White JC (1970)
Vascular complication in nephrotic syndrome: relationship to
steroid therapy and accelerated thromboplastin generation. Br
Med J 4:273–276
5
recurrent thrombosis. Patel et al. reported a case of
5. Patel R, Mandal AK (1978) Arterial thrombosis associated
with the nephrotic syndrome.
134
J Cardiovasc Surg 19:129–
recurrent thrombosis 9h after thrombectomy. Tarry et
9
al. reported recurrent thrombosis of the brachial artery
6
. Nitatori T, Niitsu K, Kudoh S, Satoh Y, Abe K (1987) Femoral
arterial thrombosis in nephrotic syndrome: steroid and long-term
heparin treatment. J Cardiovasc Surg 28:189–192
10
on postoperative day 1. Kioka et al. reported a patient
who experienced three episodes of arterial thrombosis.